HEALTHMARKETWATCH
Here’s how much Moderna’s stock has rallied off renewed focus on hantavirus research
Moderna's stock has rallied due to renewed focus on hantavirus research amid growing public concern about a potential hantavirus outbreak on a cruise sparking a new pandemic. The outbreak is raising fears of another pandemic. Moderna is working on research related to the virus.
Mentioned